Terms: = Pancreatic cancer AND SUZ12, CHET9, 23512, ENSG00000178691, Q15022, KIAA0160, JJAZ1
4 results:
1. Targeting polycomb repressor complex 2-mediated bivalent promoter epigenetic silencing of secreted frizzled-related protein 1 inhibits cholangiocarcinoma progression.
Wu G; Wang Q; Wang D; Xiong F; Liu W; Chen J; Wang B; Huang W; Wang X; Chen Y
Clin Transl Med; 2023 Dec; 13(12):e1502. PubMed ID: 38050190
[TBL] [Abstract] [Full Text] [Related]
2. Effect and Mechanism of Curcumin on EZH2 - miR-101 Regulatory Feedback Loop in Multiple Myeloma.
Wu C; Ruan T; Liu W; Zhu X; Pan J; Lu W; Yan C; Tao K; Zhang W; Zhang C
Curr Pharm Des; 2018; 24(5):564-575. PubMed ID: 28322158
[TBL] [Abstract] [Full Text] [Related]
3. Polycomb group protein expression during differentiation of human embryonic stem cells into pancreatic lineage in vitro.
Pethe P; Nagvenkar P; Bhartiya D
BMC Cell Biol; 2014 May; 15():18. PubMed ID: 24885493
[TBL] [Abstract] [Full Text] [Related]
4. Direct targeting of suz12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis.
Peng F; Jiang J; Yu Y; Tian R; Guo X; Li X; Shen M; Xu M; Zhu F; Shi C; Hu J; Wang M; Qin R
Br J Cancer; 2013 Dec; 109(12):3092-104. PubMed ID: 24169343
[TBL] [Abstract] [Full Text] [Related]
